11 Studies Published in Peer-ReviewedJournals such as these involving over 4000 subjects.
Increased Circulation
Circulation increases were measured by a Moor Scanning Laser Doppler after a 20 - 30 minute Anodyne treatment. Brighter areas in the images below indicate more circulation.
Before Treatment
After Anodyne Treatment
Heel
Up to 3200% increase
Lower Back
Up to 1300% increase
Elbow
Up to 1300% increase
Knee
Up to 2000% increase
Baseline
400% Increase
40% Increase
MIRE
Placebo
(Warmth)
Foot – Foot on left treated with Anodyne (MIRE™) showed a 400% increase in circulation while foot on right treated with a placebo heat treatment showed only a 40% increase in circulation.
All subjects in the study had chronic pain and/or circulatory deficiency in the extremities. Subjects initially received treatment with active therapy pads on one limb and sham pads on the other limb 3 times per week for 40 minutes each vist for 2 weeks (6 treatments). This was followed by six active treatments of the same duration administered to both limbs duing the following 2 weeks.
Pain Endpoint:
Numeric Visual Analog Scale from 0 – 10 (10 being the worst pain)
Results :
Group
VAS Baseline
After 6 MIRE Treatments
After12 MIRE
Treatments
P Value
1 (N=18)
4.2 + 2.3
3.2 + 1.9
2.3 + 1.7
<0.0001
2* (N=9)
4.2 + 3.9
2.6 + 2.3
2.0 + 2.3
NS
* Patients more impaired
Conclusion:
The results of the study demonstrate that treatments with near-infrared photo energy delivered in the manner specified in the study protocol resulted in a significant reduction in pain.
Pain Study #2
Study Site(s):
Multiple Site
Number of Subjects:
2239
Study Design:
Multiple Site Retrospective Chart Review based on Prospective, Repeated Measures Analysis
Protocol Used:
All subjects in the study had chronic pain and/or circulatory deficiency. The average treatment protocol was 3 x per week for 30-45 minutes for 5 weeks and included physical therapy interventions such as therapeutic exercise, neuromuscular re-education and/or gait training.
Pain Endpoint:
Numeric Visual Analog scale from 0 – 10 (10 being the worst pain)
Results :
Patients Reporting Significant Pain Pre and Post Treatment
Pre
Post
# Improved
% Improved
1563
33
1530
98%
Changes in Pain on 11 point VAS (0-10; 10 being the worst pain)
Pre
Post
# Points Improved
P-Value
% Improved
7.2 ± 2.2
2.4 ± 2.1
4.8 ± 2.4
<0.0001
67%
Conclusion:
MIRE treatments are associated with a reduction in pain, even in patients with pain levels between 8-10 on a 0-10 point scale.
Pain Study #3
Study Site(s):
Genesis Medical Center (Davenport, IA), Premier PT (Evergreen Park, IL, Orland Park, IL and Hinsdale, IL), Westside Retirement Village (Indianapolis, IN), Sonoma Valley Hospital (Sonoma, CA), Helmwood Healthcare (Elizabethtown, KY)
Number of Subjects:
272
Study Design:
This was a retrospective Chart Review in 7 facilities and was based on Prospective, Repeated Measures Analysis.
Protocol Used:
All subjects in the study had chronic pain and/or circulatory deficiency. The therapy intervention included Anodyne Therapy for pain and circulation and physical therapy interventions such as therapeutic exercise, neuromuscular re-education and/or gait training 3 x per week for an average of 6 weeks.
Pain Endpoint:
Numeric Visual Analog scale from 0 – 10 (10 being the worst pain)
Results :
Patient Demographics (Pre-Treatment)
Total
Patients
272
Male
135
Female
137
Ageª
69 ± 12.3
Mean Number of Treatments
18 ± 10.2
Treatment Time (in minutes)
34.2 ± 9.4
Pain Pre and Post Treatment
All Patients (Pain > 4)
(n = 257)
VAS Pre-Treatment
7.7 ± 1.2
VAS Post-Treatment
4.8a ± 2.2
VAS Decreases
2.9 ± 2.2
% Pain Reduction
38%
Horrible to Excruciating Pain (VAS 8.5-10)
(n = 37)
VAS Pre-Treatment
9.4 ± 0.5
VAS Post-Treatment
4.8a ± 2.7
VAS Decreases
4.6 ± 2.9
% Pain Reduction
49%
Distressing Pain (VAS 6.5-8)
(n = 189)
VAS Pre-Treatment
7.8 ± 0.4
VAS Post-Treatment
5.0a ± 1.9
VAS Decreases
2.8 ± 1.9
% Pain Reduction
36%
Discomforting Pain (VAS 4-6)
(n = 31)
VAS Pre-Treatment
5.3 ± 0.9
VAS Post-Treatment
3.5a ± 2.5
VAS Decreases
1.8 ± 2.4
% Pain Reduction
34%
a = Values expressed as mean ± SD; All post treatment measures are P<0.0001 vs. Pretreatment
Conclusion:
Use of MIRE in combination with other physical therapy interventions is associated with reduced pain.
Pain Study #4
Study Site(s):
Multiple Sites
Number of Subjects:
252
Study Design:
Retrospective Chart Review and Patient Questionnaire
Protocol Used:
All subjects in the study had chronic pain and/or circulatory deficiency in the extremities. The initial therapy intervention included Anodyne Therapy for pain and circulation and physical therapy interventions such as therapeutic exercise, neuromuscular re-education and/or gait training. Patients then used an Anodyne Therapy System at home for an average of 8 months after the initial treatment in a clinical setting.
Pain Endpoint:
Numeric Visual Analog scale from 0 – 10 (10 being the worst pain)
Results :
Pain Reduction Based on Average Number of Months Using MIRE
1-3
3-6
6-9
9-12
12+
# of Patients
36
33
22
94
67
Ave. Months after MIRE Clinical Treatment
1.2
4.0
6.7
10.1
13.3
Mean Age
75
74
76
76
76
Male/Female
23/14
20/13
9/13
44/50
40/27
% of Patients Reporting Reduction in Pain
94%
80%
91%
85%
91%
Conclusion:
The medical records indicated that 220 out of 252 patients (87%, p< 0.0001) obtained substantial reduction in pain. When patients have continuing access to MIRE in their homes following clinical treatment, there is a significant reduction in pain.
Anodyne® Therapy is an FDA-Cleared medical device for temporarily increasing circulation and reducing pain, stiffness and muscle spasm.
Anodyne® Therapy and MIRE™ are registered trademarks of Anodyne Therapy, LLC.
Anodyne Therapy is patented in the United States, Canada and Europe.